OPK

Conviction 69HealthcareScan · Mon, Aug 10, 2026

OPK$1.39+1.46%

ResistanceSupportVol 14

Vol MA14 6.13M

May 11May 28Jun 16Jul 6Jul 23Aug 10

OPKO HEALTH, INC.PHARMACEUTICAL PREPARATIONSwww.opko.com ↗

Price1.39

Change+1.46%

Gap-0.36%

Rel volume1.26×

Avg volume5.06M

Avg $ vol7.13M

SMA 201.29

SMA 501.38

SMA 2001.29

Price vs 50+0.71%

Price vs 200+8.01%

MA stackbullish

50/200 cross—

Supertrendup · 1.25

RSI (14)54

MACD hist0.01

MACD crossbull · 9d

Stoch %K / %D40 / 35

ADX (14)36

+DI / −DI33 / 13

RSI divergence—

MACD divergence—

ATR %+6.07%

ADR %5.99%

52w high1.65

52w low1.10

From 52w high-15.76%

Above 52w low+26.36%

New 52w highNo

SqueezeOff

Bollinger width34.12%

%B0.73

Donchian pos39.82%

Donchian high1.73

Donchian low1.17

AVWAP (52w high)1.47

vs AVWAP high-5.63%

AVWAP (52w low)1.36

vs AVWAP low+1.95%

OBV trendUp

Chaikin MF (20)0.02

Today vs 20d1.26×

Avg vol (14d)6.13M

Avg vol (20d)5.06M

Avg $ vol (20d)7.13M

Market cap1.04B

RS 3m (vs SPY)+16.62%

RS 6m (vs SPY)-2.73%

RS line new highNo

Trend template4/8

Technical rank68.4

1 week+6.11%

1 month+2.96%

3 months+21.93%

6 months+12.10%

1 year+13.01%

YTD+9.45%

P/E-4.60

P/B0.88

P/S1.71

P/FCF-5.44

EPS-0.3000

Div yield—

ROE-19.06%

ROA-12.34%

Debt/Eq0.00

Current3.35

EV/EBITDA-28.68

Gross margin33.93%

Net margin-37.19%

Rev growth-14.90%

EPS growth-324.02%

Price target3.00

Target upside115.83%

Analyst ratingBuy

Institutional31.42%

Ent. value739.33M

Revenue163.58M

Net income-8.42M

Gross profit80.02M

Free cash flow-190.82M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out755.09M

Employees2.27K

ListedThu, Nov 2, 1995

Free float330.12M

Float %43.5%

Short interest33.64M

Days to cover13.0d

Short volume52.5%

Squeeze score58 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.01 vs −$0.08

Last surprise+87.5% beat

Setup gradeB

Conviction69 / 100

Pattern quality—

Tech rank68.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.67

Support1.17

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OPK

All disclosures →

No recent disclosed trades by Congress in OPK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OPK · 6 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Logal Adam Sr. Vice President, CFO · Common Stock · 2026-07-24	Tax	53.27K	$65K	2026-07-24	2026-07-28
Rubin Steven D Executive VP-Administration · Common Stock · 2026-07-24	Tax	53.27K	$65K	2026-07-24	2026-07-28
MEDEL ROGER MD Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
UPPALURI SUBBARAO V Director · Stock Option (Right to Buy) · 2026-06-18	Grant	80K	—	2026-06-18	2026-06-22
Lachman Prem A Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
Yu Alice Lin-Tsing Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
PFENNIGER RICHARD C JR Director · Stock Option (Right to Buy) · 2026-06-18	Grant	60K	—	2026-06-18	2026-06-22
PAGANELLI JOHN A Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22

SEC filings

EDGAR filings in OPK · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.